371 related articles for article (PubMed ID: 28347393)
1. Brain volume changes over the first year of treatment in schizophrenia: relationships to antipsychotic treatment.
Emsley R; Asmal L; du Plessis S; Chiliza B; Phahladira L; Kilian S
Psychol Med; 2017 Sep; 47(12):2187-2196. PubMed ID: 28347393
[TBL] [Abstract][Full Text] [Related]
2. Extrastriatal dopamine D
Nørbak-Emig H; Pinborg LH; Raghava JM; Svarer C; Baaré WFC; Allerup P; Friberg L; Rostrup E; Glenthøj B; Ebdrup BH
World J Biol Psychiatry; 2017 Oct; 18(7):539-549. PubMed ID: 27782768
[TBL] [Abstract][Full Text] [Related]
3. The Effect of Antipsychotic Treatment on Cortical Gray Matter Changes in Schizophrenia: Does the Class Matter? A Meta-analysis and Meta-regression of Longitudinal Magnetic Resonance Imaging Studies.
Vita A; De Peri L; Deste G; Barlati S; Sacchetti E
Biol Psychiatry; 2015 Sep; 78(6):403-12. PubMed ID: 25802081
[TBL] [Abstract][Full Text] [Related]
4. Antipsychotic treatment effects and structural MRI brain changes in schizophrenia.
Emsley R; du Plessis S; Phahladira L; Luckhoff HK; Scheffler F; Kilian S; Smit R; Buckle C; Chiliza B; Asmal L
Psychol Med; 2023 Apr; 53(5):2050-2059. PubMed ID: 35441587
[TBL] [Abstract][Full Text] [Related]
5. Gray matter volume changes following antipsychotic therapy in first-episode schizophrenia patients: A longitudinal voxel-based morphometric study.
Guo F; Zhu YQ; Li C; Wang XR; Wang HN; Liu WM; Wang LX; Tian P; Kang XW; Cui LB; Xi YB; Yin H
J Psychiatr Res; 2019 Sep; 116():126-132. PubMed ID: 31233895
[TBL] [Abstract][Full Text] [Related]
6. Dorsal striatal volumes in never-treated patients with first-episode schizophrenia before and during acute treatment.
Emsley R; Asmal L; du Plessis S; Chiliza B; Kidd M; Carr J; Vink M
Schizophr Res; 2015 Dec; 169(1-3):89-94. PubMed ID: 26441006
[TBL] [Abstract][Full Text] [Related]
7. Neurological soft signs in first-episode schizophrenia: State- and trait-related relationships to psychopathology, cognition and antipsychotic medication effects.
Emsley R; Chiliza B; Asmal L; Kilian S; Riaan Olivier M; Phahladira L; Ojagbemi A; Scheffler F; Carr J; Kidd M; Dazzan P
Schizophr Res; 2017 Oct; 188():144-150. PubMed ID: 28130002
[TBL] [Abstract][Full Text] [Related]
8. Changes in brain regions associated with food-intake regulation, body mass and metabolic profiles during acute antipsychotic treatment in first-episode schizophrenia.
Emsley R; Asmal L; Chiliza B; du Plessis S; Carr J; Kidd M; Malhotra AK; Vink M; Kahn RS
Psychiatry Res; 2015 Aug; 233(2):186-93. PubMed ID: 26184461
[TBL] [Abstract][Full Text] [Related]
9. A multimodal analysis of antipsychotic effects on brain structure and function in first-episode schizophrenia.
Lesh TA; Tanase C; Geib BR; Niendam TA; Yoon JH; Minzenberg MJ; Ragland JD; Solomon M; Carter CS
JAMA Psychiatry; 2015 Mar; 72(3):226-34. PubMed ID: 25588194
[TBL] [Abstract][Full Text] [Related]
10. Effects of Antipsychotic Medication on Brain Structure in Patients With Major Depressive Disorder and Psychotic Features: Neuroimaging Findings in the Context of a Randomized Placebo-Controlled Clinical Trial.
Voineskos AN; Mulsant BH; Dickie EW; Neufeld NH; Rothschild AJ; Whyte EM; Meyers BS; Alexopoulos GS; Hoptman MJ; Lerch JP; Flint AJ
JAMA Psychiatry; 2020 Jul; 77(7):674-683. PubMed ID: 32101271
[TBL] [Abstract][Full Text] [Related]
11. Association between olanzapine treatment and brain cortical thickness and gray/white matter contrast is moderated by cholesterol in psychotic disorders.
Gjerde PB; Jørgensen KN; Steen NE; Melle I; Andreassen OA; Steen VM; Agartz I
Psychiatry Res Neuroimaging; 2018 Dec; 282():55-63. PubMed ID: 30415175
[TBL] [Abstract][Full Text] [Related]
12. Antipsychotic drug effects on brain morphology in first-episode psychosis.
Lieberman JA; Tollefson GD; Charles C; Zipursky R; Sharma T; Kahn RS; Keefe RS; Green AI; Gur RE; McEvoy J; Perkins D; Hamer RM; Gu H; Tohen M;
Arch Gen Psychiatry; 2005 Apr; 62(4):361-70. PubMed ID: 15809403
[TBL] [Abstract][Full Text] [Related]
13. Glutamatergic Metabolites, Volume and Cortical Thickness in Antipsychotic-Naive Patients with First-Episode Psychosis: Implications for Excitotoxicity.
Plitman E; Patel R; Chung JK; Pipitone J; Chavez S; Reyes-Madrigal F; Gómez-Cruz G; León-Ortiz P; Chakravarty MM; de la Fuente-Sandoval C; Graff-Guerrero A
Neuropsychopharmacology; 2016 Sep; 41(10):2606-13. PubMed ID: 27272768
[TBL] [Abstract][Full Text] [Related]
14. No progressive brain changes during a 1-year follow-up of patients with first-episode psychosis.
Haukvik UK; Hartberg CB; Nerland S; Jørgensen KN; Lange EH; Simonsen C; Nesvåg R; Dale AM; Andreassen OA; Melle I; Agartz I
Psychol Med; 2016 Feb; 46(3):589-98. PubMed ID: 26526001
[TBL] [Abstract][Full Text] [Related]
15. Extensive gray matter volume reduction in treatment-resistant schizophrenia.
Anderson VM; Goldstein ME; Kydd RR; Russell BR
Int J Neuropsychopharmacol; 2015 Feb; 18(7):pyv016. PubMed ID: 25716781
[TBL] [Abstract][Full Text] [Related]
16. Progressive Grey Matter Volume Changes in Patients with Schizophrenia over 6 Weeks of Antipsychotic Treatment and Their Relationship to Clinical Improvement.
Zhang X; Zhang Y; Liao J; Jiang S; Yan J; Yue W; Zhang D; Yan H
Neurosci Bull; 2018 Oct; 34(5):816-826. PubMed ID: 29779085
[TBL] [Abstract][Full Text] [Related]
17. Regional Abnormality of Grey Matter in Schizophrenia: Effect from the Illness or Treatment?
Yue Y; Kong L; Wang J; Li C; Tan L; Su H; Xu Y
PLoS One; 2016; 11(1):e0147204. PubMed ID: 26789520
[TBL] [Abstract][Full Text] [Related]
18. Progressive brain structural changes after the first year of treatment in first-episode treatment-naive patients with deficit or nondeficit schizophrenia.
Lei W; Kirkpatrick B; Wang Q; Deng W; Li M; Guo W; Liang S; Li Y; Zhang C; Li X; Zhang P; Li Z; Xiang B; Chen J; Hu X; Zhang N; Li T
Psychiatry Res Neuroimaging; 2019 Jun; 288():12-20. PubMed ID: 31059954
[TBL] [Abstract][Full Text] [Related]
19. Different effects of typical and atypical antipsychotics on grey matter in first episode psychosis: the AESOP study.
Dazzan P; Morgan KD; Orr K; Hutchinson G; Chitnis X; Suckling J; Fearon P; McGuire PK; Mallett RM; Jones PB; Leff J; Murray RM
Neuropsychopharmacology; 2005 Apr; 30(4):765-74. PubMed ID: 15702141
[TBL] [Abstract][Full Text] [Related]
20. Right superior frontal gyrus: A potential neuroimaging biomarker for predicting short-term efficacy in schizophrenia.
Yang Y; Jin X; Xue Y; Li X; Chen Y; Kang N; Yan W; Li P; Guo X; Luo B; Zhang Y; Liu Q; Shi H; Zhang L; Su X; Liu B; Lu L; Lv L; Li W
Neuroimage Clin; 2024; 42():103603. PubMed ID: 38588618
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
